The TARDBP gene gives your cells instructions for TDP-43, a protein that helps manage RNA, the messages cells use to make other proteins, especially in nerve cells. This gene plays an important role in keeping those messages organized and in the right place. If the gene does not work properly, TDP-43 can build up abnormally and damage nerve cells. Some pathogenic variants in the TARDBP gene are linked to amyotrophic lateral sclerosis and, less often, frontotemporal dementia.
What is a gene?
A gene is a stretch of DNA that holds information your cells use to make molecules or direct processes in the body. Some genes provide the instructions for making proteins, which are the working parts of cells. Other genes mainly help regulate when certain processes happen, where they happen, and how strongly they occur. Taken together, genes influence how the body grows and works, and they can affect how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
TARDBPGene function
What if the gene works
The TARDBP gene helps cells manage RNA, the working copy of genetic instructions used to make proteins. Its protein, TDP-43, helps process, move, and protect RNA, especially in nerve cells.
Risk
What if the gene does not work
Variants in the TARDBP gene are linked mainly to amyotrophic lateral sclerosis and, in some people, frontotemporal dementia. Effects can range from milder to more severe, which may influence when symptoms begin and which features appear.
Treatment
What does that mean for your treatment
No TARDBP-specific treatment or drug selection approach is currently established in clinical guidelines. The TARDBP gene is an active research target in ALS and related conditions, with therapies aimed at TDP-43 buildup and how cells handle genetic messages under study.
Conditions associated with TARDBP
Gene function
What if the gene works
Your cells use the TARDBP gene to manage RNA, the working copies of genetic instructions used to make proteins. Its protein, often called TDP-43, helps shape, move, and control these messages so cell activity stays organized. Understanding what the TARDBP gene does in your cells helps show how genetic instructions are turned into everyday cell work.
The TARDBP gene helps cells trim and join fresh RNA messages before they are used. This lets one gene make the right message forms for different cell needs.
Its protein binds to RNA and helps decide which messages are kept, stored, or broken down. That balance supports steady, well-timed protein production.
TDP-43 helps guide some RNA messages to the parts of the cell where they are needed. This helps proteins be made in the right place and at the right time.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help shape normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the TARDBP gene can alter the TDP-43 protein so it misfolds, becomes less stable, or shifts from the nucleus into the cell fluid. This TARDBP gene variant effect on protein function may disrupt RNA processing and make the protein more likely to form clumps, especially with changes in its tail region. Some variants have milder effects, while more disruptive ones often cause greater cellular stress and may be linked to earlier or more marked amyotrophic lateral sclerosis or frontotemporal dementia.
How variants are linked to conditions
Pathogenic variants in the TARDBP gene are a recognized cause of some inherited forms of amyotrophic lateral sclerosis, often called ALS. Some people with TARDBP-related ALS also develop changes linked to frontotemporal dementia, and a smaller number have frontotemporal dementia without ALS. In families being evaluated for TARDBP gene variants linked to ALS and frontotemporal dementia, the strongest evidence is for these motor neuron and cognitive conditions.
A variant is not necessarily a diagnosis
Gene variants are a routine part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors contribute. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to TARDBP. In families with a disease-causing TARDBP variant, risk is mainly shaped by the variant itself, while age and family history can also matter; anyone concerned about personal risk should speak with a doctor or genetic counselor.
Inheritance of TARDBP variants
TARDBP-related conditions are usually inherited in an autosomal dominant pattern. This means a person with a disease-causing variant in the TARDBP gene has a 50% chance of passing it on to each child, whether the child is a son or a daughter. In families affected by TARDBP-related amyotrophic lateral sclerosis or frontotemporal dementia, how TARDBP variants are inherited is usually straightforward: one altered copy of the gene can be enough to run in a family. Not everyone who inherits a variant will have the same symptoms or the same age of onset.
What does my TARDBP result mean for my family?
For TARDBP, family meaning is usually discussed in terms of a dominant pattern: close relatives such as a parent, brother, sister, or child may also carry the same gene change. That does not mean they will all have the same symptoms, age of onset, or severity, because TARDBP-related conditions can vary even within one family. Family testing discussions often focus first on first-degree relatives.
Genetic information
Genetic testing
How you find out about variants
TARDBP genetic testing looks for variants in the TARDBP gene using a blood or saliva sample. A lab reads the gene's DNA code and checks for changes that may help explain a personal or family history of amyotrophic lateral sclerosis (ALS) or frontotemporal dementia. Results usually say whether a variant was found and how clearly it is linked to disease.
When should I consider getting a genetic test?
TARDBP testing may be considered if you or a close relative has amyotrophic lateral sclerosis (ALS), especially when it runs in the family or starts at a younger age. It can also be relevant when ALS and frontotemporal dementia appear in the same family.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals depends on the condition and the kind of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put personal experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug more slowly or more quickly, so the same dose can lead to different effects from one person to another. This is a common part of normal human variation and can influence how well a treatment works or how sensitive someone is to side effects. Medication response also reflects other factors, such as age, liver and kidney function, and other medicines a person takes.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can shape their response to medicines. By studying links between genes and drugs, it helps explain why the same treatment may affect people in different ways. With many medications, genes can influence how powerfully a drug works or how the body handles it. Understanding this can support treatment decisions that are more informed and more tailored to the individual. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the TARDBP gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so any concerns about medicines, side effects, or changes in your health are best discussed with your doctor.
History
TARDBP first entered research through studies of HIV, when scientists identified a protein called TDP-43 that could bind a viral DNA sequence. In the early 2000s, awareness of this gene’s role has grown as TDP-43 was found in the abnormal protein clumps seen in many people with amyotrophic lateral sclerosis and some forms of frontotemporal dementia. That discovery was a major turning point because it connected the TARDBP gene to a broader shift in how these brain conditions were understood. From these first observations, research expanded steadily. Soon after, inherited variants in the TARDBP gene were reported in some families with ALS, linking the lab finding to human disease. These historical steps shaped today’s understanding of TARDBP as an important gene in neurodegeneration research.